Allen Institute for Artificial Intelligence
supp.ai logo
supp.ai

Discover Supplement-Drug Interactions

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 3 years ago

Possible Interaction: Cholecystokinin and Phenylalanine

Research Papers that Mention the Interaction

Basal levels of CCK were 1.10 +/- 0.12 pmol/L; 20 minutes after L-PA, CCK levels increased to 5.49 +/- 0.83 pmol/L. There was no increase in CCK following D-PA or placebo.
Release of CCK by L-PA is associated with a reduction in subsequent food intake, and this suggests that CCK is an important satiety hormone in humans.
Metabolism: clinical and experimental  •  1994  |  View Paper
At more than 20 mm, Phe induced dose‐dependent CCK secretion and intracellular Ca2+ mobilization in STC‐1 cells.
In the presence of 3.0 mm extracellular Ca2+, 10 and 20 mm Phe induced significantly higher CCK secretion than under normal conditions (1.2 mm extracellular Ca2+).
Intraluminal l‐phenylalanine (Phe) stimulates cholecystokinin (CCK) secretion in vivo and in vitro.
The FEBS journal  •  2008  |  View Paper
In conclusion, our observations indicate that the energy intake-suppressant effect of phenylalanine is related to the stimulation of CCK and PYY, while the glucoregulatory effect may be independent of stimulation of plasma GLP-1 or slowing of gastric emptying.
In humans, phenylalanine stimulates plasma cholecystokinin (CCK) and pyloric pressures, both of which are important in the regulation of energy intake and gastric emptying.
Nutrients  •  2020  |  View Paper
l-phenylalanine Phe ) has been shown to elicit release of the gut hormone cholecystokinin (CCK) and reduce energy intake.
Physiology & Behavior  •  2008  |  View Paper
Immunoreactive cholecystokinin was significantly stimulated to 9.4±1.4pmol/l only by intraduodenal phenylalanine.
Diabetologia  •  2004  |  View Paper
… -phenylalanine (… cholecystokinin (CCK) plasma concentrations and duodenal bile salt output (p less than 0.005) as compared with a control electrolyte solution, but did not change … mmol), isoleucine (21.5 mmol), lysine (31 mmol), threonine (23 mmol) - did not change CCK plasma concentrations, bile salt or pancreatic enzyme output.
Gut  •  1988  |  View Paper
In contrast, intraduodenal perfusion of phenylalanine (10 mM) produced a significant increase in plasma CCK levels (6.7 +/- 0.8 pM) and a three- to fourfold increase in pancreatic enzyme outputs.
Gastroenterology  •  1986  |  View Paper
Phenylalanine increased the concentrations of plasma insulin, cholecystokinin , and pancreatic DNA (mg/g) and the expression of trypsin gene but decreased the pancreatic protein:DNA ratio and tended to decrease the pancreas weight (g/kg of BW).
Journal of dairy science  •  2018  |  View Paper
Administration of phenylalanine inhibited basal K(+) channel activity and caused CCK cell depolarization, consistent with changes necessary for hormone secretion.
Phenylalanine and tryptophan stimulated CCK release from intestinal CCK cells, and this stimulation was also blocked by CaSR inhibition.
American journal of physiology. Gastrointestinal and liver physiology  •  2011  |  View Paper
Additionally, CCK secretion by an isolated I cell population was increased by 30 and 62% in response to L-Phe in the presence of physiological (1.26 mM) and superphysiological (2.5 mM) extracellular calcium concentrations, respectively.
American journal of physiology. Gastrointestinal and liver physiology  •  2011  |  View Paper
Show More